EMA
withdrawal
· 2025-05-06
EMA Withdrawn: Arsenic trioxide Mylan (arsenic trioxide) — Mylan Ireland Limited
Summary
The EMA has withdrawn the arsenic trioxide product Arsenic trioxide Mylan (Mylan Ireland Limited) used for acute promyelocytic leukemia.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Status: Withdrawn. Therapeutic area: Leukemia, Promyelocytic, Acute. MAH: Mylan Ireland Limited. Decision date: 14/01/2025